Subscribe To
Kineta to Host Key Opinion Leader Event on KVA12123: VISTA as an Immuno-Oncology Target
SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today it will host a virtual Key Opinion Leader (KOL) event on VISTA as an immuno-oncology target on Monday, March 20, 2023 at 10:00 AM ET. The event will […] The post Kineta to Host Key Opinion Leader Event on KVA12123: VISTA as an Immuno-Oncology Target appeared first on ForexTV...
Read More
Posted: Mar 6 2023, 11:30
Author Name: forextv
Views: 110698